LEN Lennar Corporation Class A

Lennar Brings Two Communities of New Homes to Carson City

Northern Nevada’s largest homebuilder Lennar will grand open two new home communities on Sunday, October 30 with a special ribbon cutting ceremony at 10 a.m. Sierra Crossing and Eagles Station at Schulz Ranch represent the largest new home community development to come to Carson City in a long time. Prospective homebuyers and community members are invited to the event to tour model homes, enjoy complimentary food and partake in a live radio broadcast.

“We are thrilled to be opening these new communities in Carson City, a place that hasn’t seen a new home development of this scale in a long time,” said Dustin Barker, Division President for Lennar Northern Nevada. “These communities provide a unique opportunity to purchase a single-family home only 25 minutes away from South Lake Tahoe.”

Eagle Station at Schulz Ranch will feature three distinctive single-story floorplans for buyers to choose from, including a Next Gen® – The Home Within A Home® floorplan, The Shire. This home boasts approximately 2,547 square feet and includes an attached private suite complete with separate entrance, living room, bedroom, kitchenette and laundry area. The Shire offers four bedrooms and three bathrooms in total, along with a spacious three-bay garage.

Also at Eagle Station, the Comstock provides approximately 2,200 square feet that includes three bedrooms, two bathrooms, a den and three-bay garage. The Ponderosa model features approximately 2,400 square feet with four bedrooms, three bathrooms and a three-bay garage.

Sierra Crossing will offer three distinctive floorplans to choose from. The La Mesa plan spans approximately 1,744 square feet and includes four bedrooms, two bathrooms and a three-bay garage. The Cottonwood plan provides approximately 1,953 square feet, four bedrooms, two bathrooms and a three-bay garage. Lastly, The Highland plan gives approximately 2,100 square feet with four bedrooms, three bathrooms and a three-bay garage.

Every home at Schulz Ranch is part of Lennar’s Everything’s Included® program, which adds value to every new Lennar home by including a high level of upscale features at no added cost to the buyer. As Schulz Ranch, Lennar homeowners enjoy granite countertops, stainless steel appliances, upgraded cabinetry, flooring and more.

The event will be held Sunday, October 30, from 10 a.m. to 6 p.m. at the Schulz Ranch Welcome Home Center. To find these two new communities, head South on Highway 395, turn left onto Topsy Lane and continue to the model homes.

For more information on this community, visit www.lennar.com/reno.

With hundreds of communities nationwide and homes designed for first-time, move-up and luxury homebuyers, Lennar has grown to become one of the nation’s leading and most respected homebuilders and proudly remains steadfast in their commitment toward quality, value and integrity. Lennar has a longstanding history of building exceptional homes in only the most well planned and desirable locations throughout the country.

EN
25/10/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lennar Corporation Class A

Lennar Corp: 1 director

A director at Lennar Corp bought 1,575 shares at 157.000USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

Wedbush Research
  • Wedbush Research
LOGN LOGITECH INTERNATIONAL S.A.
KMX CARMAX INC.
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
SGMO SANGAMO THERAPEUTICS INC.
RHP RYMAN HOSPITALITY PROPERTIES INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PCRX PACIRA BIOSCIENCES INC.
NVCR NOVOCURE LTD.
NCMI NATIONAL CINEMEDIA INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MTH MERITAGE HOMES CORPORATION
LGIH LGI HOMES INC.
LEN LENNAR CORPORATION CLASS A
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
IMAX IMAX CORPORATION
GPRO GOPRO INC. CLASS A
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
CNK CINEMARK HOLDINGS INC.
CMRX CHIMERIX INC
CCS CENTURY COMMUNITIES INC.
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ARDX ARDELYX INC
AMC AMC ENTERTAINMENT HOLDINGS INC. CLASS A
NFLX NETFLIX INC.
DHI D.R. HORTON INC.
FRX_CN FENNEC PHARMACEUTICALS
PVH PVH CORP.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
ROKU ROKU INC. CLASS A
AMZN AMAZON.COM INC.
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SURF SURFACE ONCOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
BCEL ATRECA
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
PRAX PRAXIS PRECISION MEDICINES
FUBO FUBOTV
CURA CURALEAF HOLDINGS
TVTX TRAVERE THERAPEUTICS INC
VRDN VIRIDIAN THERAPEUTICS INC
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
OMGA OMEGA THERAPEUTICS
LBPH LONGBOARD PHARMACEUTICALS
THRX THESEUS PHARMACEUTICALS
DSGN INC.
ATXS DESIGN THERAPEUTICS INC
AVTE ASTRIA THERAPEUTICS INC
RLYB AEROVATE THERAPEUTICS INC
KRTX RALLYBIO CORP
FUSN KARUNA THERAPEUTICS INC
VIGL FUSION PHARMACEUTICALS INC
EWTX VIGIL NEUROSCIENCE INC
EDGEWISE THERAPEUTICS INC

ResearchPool Subscriptions

Get the most out of your insights

Get in touch